Selinexor Misses Primary Endpoint in Endometrial Cancer Trial Medical Professionals Reference
Selinexor Misses Primary Endpoint in Endometrial Cancer Trial empr.com
To investigate whether the etiology of diminished ovarian reserve (DOR) independently influences outcomes of assisted reproductive technology (ART).
Cardiothoracic involvement by obstetric and gynecologic pathologic conditions creates a broad spectrum of clinical and radiologic manifestations, ranging from mild to critical. The authors describe the unique and often unrecognized …
To investigate, using transvaginal ultrasound imaging, the overlap between polycystic ovarian morphology (PCOM) and endometriosis, and to explore demographic and clinical factors associated with their coexistence across endometriosis phenotypes.
Accurate and standardised characterisation of endometriosis extent is essential for patient counselling regarding pain and fertility outcomes, surgical planning, multidisciplinary communication, and clinical research. The Enzian classification has been applied …
To estimate prevalence of pelvic floor tension myalgia and pelvic floor myalgia among individuals with endometriosis. The secondary outcome is to determine specific symptoms suggestive of pelvic floor tension myalgia/pelvic …
Endometriosis is a prevalent gynecological condition affecting up to 25-40% of women with infertility. Endoferin, a protein complex derived from the bovine ovarian follicles, has demonstrated high efficacy in clinical …
Expanded women's health clinic provides holistic approach to complex issues psnews.com.au
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint TipRanks